Chenodeoxycholic acid Leadiant (previously known as Chenodeoxycholic acid sigma-tau) European Union - English - EMA (European Medicines Agency)

chenodeoxycholic acid leadiant (previously known as chenodeoxycholic acid sigma-tau)

leadiant gmbh - chenodeoxycholic acid - xanthomatosis, cerebrotendinous; metabolism, inborn errors - bile and liver therapy - chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (ctx)) in infants, children and adolescents aged 1 month to 18 years and adults.

CHENODEOXYCHOLIC ACID LEADIANT Israel - English - Ministry of Health

chenodeoxycholic acid leadiant

mbi pharma ltd., israel - chenodeoxycholic acid - hard capsule - chenodeoxycholic acid 250 mg - chenodeoxycholic acid - the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (ctx)) in infants, children and adolescents aged 1 month to 18 years and adults.

Chendol New Zealand - English - Medsafe (Medicines Safety Authority)

chendol

artex limited - chenodeoxycholic acid 125mg - capsule - 125 mg - active: chenodeoxycholic acid 125mg

Kebilis New Zealand - English - Medsafe (Medicines Safety Authority)

kebilis

sanofi-aventis new zealand limited - chenodeoxycholic acid 250mg - tablet - 250 mg - active: chenodeoxycholic acid 250mg

CHINO Capsules 125 (チノカプセル125) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

chino capsules 125 (チノカプセル125)

fujimoto pharmaceutical corporation - chenodeoxycholic acid - green capsule, major axis:15.8 mm, minor axis:5.8 mm